Among the screened metabolites, glucosylceramides, lysophosphatidylcholines, and triacylglycerides were shown to be associated with CSF Aβ, while sphingomyelins and ceramides were found to be associated with CSF total tau and brain atrophy. This evidence concerns the gene MAPT and Brain atrophy.